-The Hindu Business Line The Ayushman Bharat programme must aim to reverse poverty caused by healthcare expenses The state of India’s healthcare system is somewhat dichotomous — the country is a global supplier of life-saving, affordable and good quality generic medicines, yet lakhs of families are driven into poverty because they are forced to spend much of their earnings and savings on medications to treat chronic and life-threatening diseases. The poor, pARTicularly,...
More »SEARCH RESULT
Total Matching Records found : 12283
Jharkhand villagers ask why should they lose land for Adani project supplying power to Bangladesh -Aruna Chandrasekhar
-Scroll.in How does the project qualify as ‘public purpose’ and does it violate legal safeguards for Santhal areas? PART 2 of a Scroll.in investigation on the Godda plant. In the villages of Motiya and Gangta in Jharkhand’s Godda district, tractors and SUVs race down a recently widened dirt road. Even in the clouds of dust they kick off, it is hard to miss the fence stretching across kilometres of farmland, with cows...
More »The Age of Surplus -Harish Damodaran
-The Indian Express We have, indeed, entered a regime of “permanent surpluses” in most crops — a reality our policymakers are unable to grasp, stuck as they are in the era of the Essential Commodities Act. If there is one thing that has changed in Indian agriculture in recent times, it is supply response — the ability of farmers to increase production when prices go up. Traditionally, the supply curve in most...
More »Violence cost India's GDP over $1 trn on PPP basis
-PTI The estimates include the direct and indirect cost of violence as well as an economic multiplier New Delhi: Violence cost the Indian economy a whopping USD 1.19 trillion (over Rs 80 lakh crore) last year in constant purchasing power parity (PPP) terms, which amounts to roughly USD 595.4 per person, says a report. The findings are pART of the report prepared by the Institute for Economics and Peace (IEP) based on...
More »Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel
-The Indian Express The DepARTment of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to...
More »
